10/9/2026
FDA faces internal dissent over HHS peptide legalization
HHS plans to allow unapproved peptides, sparking FDA staff concerns.
Topic archive
peptides
2 stories
7/24/2026
Heidi Overton's role in Trump's ibogaine policy
White House adviser Heidi Overton shapes ibogaine policy amid internal disputes.